Serlin Says Bioline Chases U.S. Investors on Nasdaq

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

July 25 (Bloomberg) -- Philip Serlin, chief financial officer of Bioline RX Ltd., discusses the start of trading today of the company's American depositary receipts on the Nasdaq Stock Market. Serlin spoke with Bloomberg's Gwen Ackerman on July 20 in Jerusalem. (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change